New Delhi, 29 May 2013: Max India Ltd, one of India's leading multi-business corporates, today announced consolidated Profit After Tax (PAT) for the year ended March 31, 2013 of Rs. 784 Cr, more than four times the PAT for FY 2012 (Rs 155 Cr). Profit for the year ended March 31, 2013 included a onetime gain from the transaction that involved the entry of Mitsui Sumitomo Insurance, Japan as a joint venture partner in Max India's subsidiary Max Life Insurance. Consolidated revenues for FY 2013 grew by 24% to Rs 10,624 Cr.

The Board of Directors of Max India recommended a Dividend of 110% for its shareholders, which translates to Rs 2.20 per share. The total Dividend for the year thus stands at 610% or Rs 12.20 per share and will result in an outgo of Rs. 324 Cr.

Commenting on the company's performance,Mr. Rahul Khosla, Managing Director, Max India Ltd.said, "We have performed well despite a generally challenging macroeconomic environment and a fluid regulatory situation.A healthy balance sheet coupled with good performance has given us the flexibility to reward shareholders in the form of substantial Dividends this year (610%). Each of our businesses of life insurance, health insurance and healthcare enjoy strong positions in their respective categories, continue to grow faster than the market and represent significant headroom for sustained high growth in their respective categories. In addition, our new businesses, such as senior living show great promise."

Max India has complemented excellent operational performance with a focus on enhancing capital efficiency, capturing enterprise synergies and seeding future growth through expansion in the business portfolio. In FY 2013, Mitsui Sumitomo Insurance, of MS&AD Group, Japan acquired 26% stake in Max India's life insurance business, Max Life Insurance Company. Additionally, in Jan 2012, Life Healthcare, a leading healthcare operator in Africa, acquired 26% stake in Max India's healthcare business, Max Healthcare for Rs 516 Cr.

Earlier this week, Max Life, a 71% subsidiary of Max India declared a final dividend of Rs 159 Cr supported by a 17% growth in PBT for FY 2013 to Rs 860 Cr. This takes the total Dividend from Max Life for FY 2013 to Rs 259 Cr.

Subsidiaries

Max Life Insurance Company Ltd.(Formerly Max New York Life Insurance Co. Ltd.) - The Company was incorporated in the year 2000 in partnership with New York Life (NYL), a Fortune 100 company. In April 2012, Mitsui Sumitomo Insurance Co. Ltd. (MSI), an MS&AD Insurance Group Holdings Company, which is amongst the top general insurers in the world acquired 26% stake in the company from New York Life Enterprise (NLYE). Subsequently the company was renamed Max Life Insurance Co. Ltd.

Max Life Insurance, a Rs 66 billion (USD 1.2 billion) company, has retained its position as the largest non-bank-promoted private life insurance company and is the 4th largest private life insurance company in India. The company offers comprehensive product solutions for long-term savings and protection to its over 30 lakh customers. It has a country-wide diversified distribution model including 35,000 agent advisors, exclusive arrangement with Axis Bank - India's 3rdlargest private bank and several other partners.

Max Life Insurance is a quality business focused on delivering excellence to customers through advice based sale process, customer centric approach to business, financial stability & investment expertise and strong human capital.

Max Healthcare (MHC)is the country's leading comprehensive provider of standardized, seamless and international-class healthcare services, especially focused on tertiary and quaternary care. It is committed to the highest standards of medical and service excellence, patient care, scientific and medical education.

Max Healthcare operates 12 facilities in North India, offering services in over 30 medical disciplines. Of this, 9 facilities are located in Delhi & NCR and the others in Mohali, Bathinda and Dehradun. The Max network includes state-of-the-art tertiary care hospitals in Saket, Patparganj, Shalimar Bagh, Mohali, Bathinda and Dehradun, secondary care hospitals at Gurgaon, Pitampura and Noida and an out-patient facility and a speciality centre at Panchsheel Park. The super speciality hospitals in Mohali, Bathinda, Dehradun and Shalimar Bagh were commissioned in FY 2012 and have led to doubling of Max Healthcare's capacity to nearly 2000 beds.

The tertiary care hospitals at Saket, Patparganj and Shalimar Bagh are centres of excellence for Cardiac Care, Minimal Access, Metabolic & Bariatric Surgery, Cancer Care, Orthopaedics & Joint Replacement, Neurosciences, Paediatrics, Obstetrics & Gynaecology, Aesthetic & Reconstructive Plastic Surgery and Internal Medicine. In addition, they offer services in the disciplines of Urology, ENT, Gastroenterology, Nephrology, Dermatology, Mental Health & Behavioural Sciences amongst others.

The Super Speciality Hospitals in Mohali and Bathinda are under PPP arrangement with the Government of Punjab and have tertiary care facilities in cancer care, cardiac care, neurology, orthopaedics and trauma. The recently launched Super Speciality Hospital in Dehradun is the latest addition to the Max Healthcare network and offers comprehensive tertiary, secondary and primary care services.

Max Healthcare is a pioneer in the introduction of technology to provide patients with the highest standards in medical care. Examples are the first Brain Suite in Asia at Max Saket and the Electronic Health Record System in use across Max Hospitals. The hospitals are equipped with the advanced medical equipment like state-of-the-art Cath labs, OTs with HEPA, Nuclear Medicine, Gama Camera, LINAC for Radiotherapy and MRI and CT scan machines.

Max Healthcare has over 1,600 leading doctors, 5,400 employees and has treated over 16, 00,000 patients from over 80 countries.

distributed by